| Published Application/Species/Sample/Dilution | Reference |
|---|
- immunohistochemistry; mouse; loading ...; fig 1l
| Zheng J, Yao L, Zhou Y, Gu X, Wang C, Bao K, et al. A novel function of NLRP3 independent of inflammasome as a key transcription factor of IL-33 in epithelial cells of atopic dermatitis. Cell Death Dis. 2021;12:871 pubmed publisher |
- western blot; human; loading ...; fig 1a
| Stav Noraas T, Edelmann R, Poulsen L, Sundnes O, Phung D, Küchler A, et al. Endothelial IL-33 Expression Is Augmented by Adenoviral Activation of the DNA Damage Machinery. J Immunol. 2017;198:3318-3325 pubmed publisher |
| Däbritz J, Judd L, Chalinor H, Menheniott T, Giraud A. Altered gp130 signalling ameliorates experimental colitis via myeloid cell-specific STAT3 activation and myeloid-derived suppressor cells. Sci Rep. 2016;6:20584 pubmed publisher |
- immunocytochemistry; human; 1:200; fig 1
| Reine T, Vuong T, Rutkovskiy A, Meen A, Vaage J, Jenssen T, et al. Serglycin in Quiescent and Proliferating Primary Endothelial Cells. PLoS ONE. 2015;10:e0145584 pubmed publisher |
- immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 2Di
| Judd L, Heine R, Menheniott T, Buzzelli J, O Brien Simpson N, Pavlic D, et al. Elevated IL-33 expression is associated with pediatric eosinophilic esophagitis, and exogenous IL-33 promotes eosinophilic esophagitis development in mice. Am J Physiol Gastrointest Liver Physiol. 2016;310:G13-25 pubmed publisher |
- immunohistochemistry - frozen section; mouse; fig 1
| Chen H, Sun Y, Lai L, Wu H, Xiao Y, Ming B, et al. Interleukin-33 is released in spinal cord and suppresses experimental autoimmune encephalomyelitis in mice. Neuroscience. 2015;308:157-68 pubmed publisher |
- immunohistochemistry - paraffin section; human; 1:500
- immunocytochemistry; human; 1:1000
| Demyanets S, Kaun C, Pentz R, Krychtiuk K, Rauscher S, Pfaffenberger S, et al. Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature. J Mol Cell Cardiol. 2013;60:16-26 pubmed publisher |
- blocking or activating experiments; mouse
| Kaieda S, Wang J, Shnayder R, Fishgal N, Hei H, Lee R, et al. Interleukin-33 primes mast cells for activation by IgG immune complexes. PLoS ONE. 2012;7:e47252 pubmed publisher |
- immunohistochemistry - paraffin section; human; 5 ug/ml
- western blot; human; 5 ug/ml
| Sundlisaeter E, Edelmann R, Hol J, Sponheim J, Küchler A, WEISS M, et al. The alarmin IL-33 is a notch target in quiescent endothelial cells. Am J Pathol. 2012;181:1099-111 pubmed publisher |
- immunohistochemistry - frozen section; human
| Kamekura R, Kojima T, Takano K, Go M, Sawada N, Himi T. The role of IL-33 and its receptor ST2 in human nasal epithelium with allergic rhinitis. Clin Exp Allergy. 2012;42:218-28 pubmed publisher |
- immunohistochemistry; human
- western blot; human
| Granne I, Southcombe J, Snider J, Tannetta D, Child T, Redman C, et al. ST2 and IL-33 in pregnancy and pre-eclampsia. PLoS ONE. 2011;6:e24463 pubmed publisher |
- immunohistochemistry - paraffin section; human; 1:1000
| Demyanets S, Konya V, Kastl S, Kaun C, Rauscher S, Niessner A, et al. Interleukin-33 induces expression of adhesion molecules and inflammatory activation in human endothelial cells and in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 2011;31:2080-9 pubmed publisher |
| Huang H, Tsai S, Wu H, Huang H, Hsieh H, Kuo Y, et al. Chronic exposure to high fat diet triggers myelin disruption and interleukin-33 upregulation in hypothalamus. BMC Neurosci. 2019;20:33 pubmed publisher |
| Travers J, Rochman M, Miracle C, Habel J, Brusilovsky M, Caldwell J, et al. Chromatin regulates IL-33 release and extracellular cytokine activity. Nat Commun. 2018;9:3244 pubmed publisher |
| Scott I, Majithiya J, Sandén C, Thornton P, Sanders P, Moore T, et al. Interleukin-33 is activated by allergen- and necrosis-associated proteolytic activities to regulate its alarmin activity during epithelial damage. Sci Rep. 2018;8:3363 pubmed publisher |
| Furukawa S, Moriyama M, Miyake K, Nakashima H, Tanaka A, Maehara T, et al. Interleukin-33 produced by M2 macrophages and other immune cells contributes to Th2 immune reaction of IgG4-related disease. Sci Rep. 2017;7:42413 pubmed publisher |
| Stojkovic S, Kaun C, Basílio J, Rauscher S, Hell L, Krychtiuk K, et al. Tissue factor is induced by interleukin-33 in human endothelial cells: a new link between coagulation and inflammation. Sci Rep. 2016;6:25171 pubmed publisher |
| Porsbjerg C, Baines K, Gibson P, Bergqvist A, Erjefält J, Sverrild A, et al. IL-33 is related to innate immune activation and sensitization to HDM in mild steroid-free asthma. Clin Exp Allergy. 2016;46:564-74 pubmed publisher |
| O Donnell C, Mahmoud A, Keane J, Murphy C, White D, Carey S, et al. An antitumorigenic role for the IL-33 receptor, ST2L, in colon cancer. Br J Cancer. 2016;114:37-43 pubmed publisher |
| Calvén J, Akbarshahi H, Menzel M, Ayata C, Idzko M, Bjermer L, et al. Rhinoviral stimuli, epithelial factors and ATP signalling contribute to bronchial smooth muscle production of IL-33. J Transl Med. 2015;13:281 pubmed publisher |
| Lam M, Hull L, Imrie A, Snidvongs K, Chin D, Pratt E, et al. Interleukin-25 and interleukin-33 as mediators of eosinophilic inflammation in chronic rhinosinusitis. Am J Rhinol Allergy. 2015;29:175-81 pubmed publisher |
| Millar N, Gilchrist D, Akbar M, Reilly J, Kerr S, Campbell A, et al. MicroRNA29a regulates IL-33-mediated tissue remodelling in tendon disease. Nat Commun. 2015;6:6774 pubmed publisher |
| Malcolm J, Awang R, Oliver Bell J, Butcher J, Campbell L, Adrados Planell A, et al. IL-33 Exacerbates Periodontal Disease through Induction of RANKL. J Dent Res. 2015;94:968-75 pubmed publisher |
| Suttle M, Enoksson M, Zoltowska A, Chatterjee M, Nilsson G, Harvima I. Experimentally induced psoriatic lesions associate with rapid but transient decrease in interleukin-33 immunostaining in epidermis. Acta Derm Venereol. 2015;95:536-41 pubmed publisher |
| Shao D, Perros F, Caramori G, Meng C, Dormuller P, Chou P, et al. Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension. Biochem Biophys Res Commun. 2014;451:8-14 pubmed publisher |
| Carlock C, Wu J, Zhou C, Tatum K, Adams H, TAN F, et al. Unique temporal and spatial expression patterns of IL-33 in ovaries during ovulation and estrous cycle are associated with ovarian tissue homeostasis. J Immunol. 2014;193:161-9 pubmed publisher |
| Seltmann J, Werfel T, Wittmann M. Evidence for a regulatory loop between IFN-? and IL-33 in skin inflammation. Exp Dermatol. 2013;22:102-7 pubmed publisher |
| Roussel L, Farias R, Rousseau S. IL-33 is expressed in epithelia from patients with cystic fibrosis and potentiates neutrophil recruitment. J Allergy Clin Immunol. 2013;131:913-6 pubmed publisher |
| Yasuda K, Muto T, Kawagoe T, Matsumoto M, Sasaki Y, Matsushita K, et al. Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice. Proc Natl Acad Sci U S A. 2012;109:3451-6 pubmed publisher |
| Kakkar R, Hei H, Dobner S, Lee R. Interleukin 33 as a mechanically responsive cytokine secreted by living cells. J Biol Chem. 2012;287:6941-8 pubmed publisher |
| Akcay A, Nguyen Q, He Z, Turkmen K, Won Lee D, Hernando A, et al. IL-33 exacerbates acute kidney injury. J Am Soc Nephrol. 2011;22:2057-67 pubmed publisher |
| Ali S, Mohs A, Thomas M, Klare J, Ross R, Schmitz M, et al. The dual function cytokine IL-33 interacts with the transcription factor NF-?B to dampen NF-?B-stimulated gene transcription. J Immunol. 2011;187:1609-16 pubmed publisher |
| Ohno T, Oboki K, Morita H, Kajiwara N, Arae K, Tanaka S, et al. Paracrine IL-33 stimulation enhances lipopolysaccharide-mediated macrophage activation. PLoS ONE. 2011;6:e18404 pubmed publisher |
| Louten J, Rankin A, Li Y, Murphy E, Beaumont M, Moon C, et al. Endogenous IL-33 enhances Th2 cytokine production and T-cell responses during allergic airway inflammation. Int Immunol. 2011;23:307-15 pubmed publisher |
